Evidence map›Paper›PMID 36826303›Full record

ArticleGels (Basel, Switzerland)2023

Outstanding Sorption of Copper (II) Ions on Porous Phenothiazine-Imine-Chitosan Materials.

Andrei Bejan, Luminita Marin

Open access · goldAbstract read
In one paragraph

Article in Gels (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Andrei Bejan"Petru Poni" Institute of Macromolecular Chemistry, Gr. Ghica Voda Alley, 41A, 700487 Iasi, Romania.ORCID 0000-0001-5891-2545
Luminita Marin"Petru Poni" Institute of Macromolecular Chemistry, Gr. Ghica Voda Alley, 41A, 700487 Iasi, Romania.ORCID 0000-0003-3987-4912
Romanian Academy · RO

Funding

Unitatea Executiva Pentru Finantarea Invatamantului Superior a Cercetarii Dezvoltarii si Inovarii PCE2/2021
6 · The paper itself

Abstract

The aim of this work was to investigate the ability of a solid-state material, prepared by crosslinking chitosan with a phenothiazine-based aldehyde, to remove copper (II) ions from aqueous solutions, in a fast and selective manner. The metal uptake experiments, including the retention, sensibility, and selectivity against eight different metal ions, were realized via batch adsorption studies. The capacity of the material to retain copper (II) ions was investigated by spectrophotometric measurements, using poly(ethyleneimine) complexation agent, which allowed detection in a concentration range of 5-500 µM. The forces driving the copper sorption were monitored using various methods, such as FTIR spectroscopy, X-ray diffraction, SEM-EDAX technique, and optical polarized microscopy, and the adsorption kinetics were assessed by fitting the in vitro sorption data on different mathematical models. The phenothiazine-imine-chitosan material proved high ability to recover copper from aqueous media, reaching a maximum retention capacity of 4.394 g Cu (II)/g adsorbent when using a 0.5 M copper solution, which is an outstanding value compared to other chitosan-based materials reported in the literature to this date. It was concluded that the high ability of the studied xerogel to retain Cu (II) ions was the result of both physio- and chemo-sorption processes. This particular behavior was favored on one hand by the porous nature of the material and on the other hand by the presence of amine, hydroxyl, imine, and amide groups with the role of copper ligands.

Indexed as

chitosancopper retentionphenothiazine

Identifiers

PMID36826303
PMCPMC9957313
OpenAlexW4319318403

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.